Premium
Latest Articles
Premium
Shares
Is South32 a buy?
At $4.12, is South32 worth buying for reasons other than simply having graduated to the S&P/ASX 20 index? Here’s my view…
Premium
Shares
4 oil & gas stars
Here are four of what I think are highly attractive oil and gas opportunities on the ASX.
Premium
Shares
My 3 Meditech picks
In my article today I want to look at the devices part of the biotech world: here are 3 examples of some of the wonderful technology coming out of Australia and being taken to a global market.
Premium
Shares
3 emerging copper stars
Companies bringing new copper production to the market over the next few years can expect to be looked upon very favourably by the market. Here are what I think are 3 outstanding prospects on the ASX.
Premium
Shares
2 stocks under 10 cents
Can there possibly be good buying in single-digit share prices? I’ve been trawling through the ASX-listed population looking for this kind of situation, and here are two single-digit share prices that I think fit the bill
Premium
Shares
4 biotechs with major news coming this year
The fact of biotech investing is that the share prices are at the mercy of news flow from drug trial results, partnerships with bigger companies, regulatory interactions and a wide range of other events that can point to the increased – or decreased – likelihood of the drug, medical device or diagnostic test ever reaching the market.
Premium
Shares
3 quality Kiwi stocks
There’s no shortage of world-class innovation coming out of our neighbour across the ditch. Here are three Kiwi stocks that I think are global standouts in their fields — and each of these, for various reasons, looks to be alluringly cheap right now.
Premium
Shares
3 ASX-listed overseas stocks
Here are three of the best (non-Kiwi) foreign listings: Block (Afterpay), Resmed and Zimplats.
Premium
Shares
4 solid-material recycling stocks
Here’s a look at 4 of the solid- material recycling stocks that I see as leading the way in the “circular economy.”